{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-21-000021","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2021-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.527482+00:00","generated_at":"2026-06-29T06:16:09.330532+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cooper Q3 revenue up 32% to $763.4M; non-GAAP EPS $3.41, up 50%; raises FY guidance","bullets":["Revenue $763.4M (+32% YoY); CooperVision $557.5M (+24%), CooperSurgical $205.9M (+60%).","Non-GAAP diluted EPS $3.41, up 50% YoY; GAAP EPS $12.37 (prior Q3: $1.12).","Free cash flow $180.2M; net debt $1,507.8M, adjusted leverage 1.52x.","FY2021 guidance: revenue $2,893-2,923M, non-GAAP EPS $13.20-13.40; Q4 revenue $730-760M.","Gross margin 68% (non-GAAP), up from 66%; operating margin 27% non-GAAP vs 23% last year."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-21-000021","json":"https://secwatch.observer/filing/0000711404-21-000021.json","markdown":"https://secwatch.observer/filing/0000711404-21-000021.md","text":"https://secwatch.observer/filing/0000711404-21-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140421000021/0000711404-21-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140421000021/coo-20210902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T06:16:09.330532+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}